Format

Send to

Choose Destination
See comment in PubMed Commons below
Transplant Rev (Orlando). 2009 Jan;23(1):1-10. doi: 10.1016/j.trre.2008.08.003.

Lymphocytes and ischemia-reperfusion injury.

Author information

  • 1Nephrology Division, Johns Hopkins University, Baltimore, MD 21205, USA.

Abstract

Ischemia reperfusion injury (IRI) is a common and important clinical problem in many different organ systems, including kidney, brain, heart, liver, lung, and intestine. IRI occurs during all deceased donor organ transplants. IRI is a highly complex cascade of events that includes interactions between vascular endothelium, interstitial compartments, circulating cells, and numerous biochemical entities. It is well established that the innate immune system, such as complement, neutrophils, cytokines, chemokines, and macrophages participate in IRI. Recent data demonstrates an important role for lymphocytes, particularly T cells but also B cells in IRI. Lymphocytes not only participate in augmenting injury responses after IRI, but could also be playing a protective role depending on the cell type and stage of injury. Furthermore, lymphocytes appear to be participating in the healing response from IRI. These new data open the possibility for lymphocyte targeted therapeutics to improve the short and long term outcomes from IRI.

PMID:
19027612
PMCID:
PMC2651229
DOI:
10.1016/j.trre.2008.08.003
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center